Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharmatek Adds Spray Drying Capabilities | Contract Pharma
Breaking News

Pharmatek Adds Spray Drying Capabilities

Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities with the purchase of a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.

Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities with the purchase of a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture. This technology can be used for both oral and parenteral dosage forms.

“Spray drying is an integral technology in Pharmatek’s toolkit for formulating insoluble compounds. The high degree of control and reduced process steps afforded by this process offer a number of advantages over other formulation techniques: enhanced robustness and reproducibility, and the ability to control and create uniform particle size and stabilize volatile and thermo-sensitive compounds,” said Jeffrey Bibbs, chief executive officer and chief scientific officer of Pharmatek.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters